Actinium Pharmaceuticals Inc (ATNM) earnings · rev $90.0K
These earnings events as JSON? API free 100/dayActinium Pharmaceuticals Inc (ATNM) is a biotechnology company listed on US.
This ATNM earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported ATNM revenue for 2025-12-31 was $90.0K. Net income was -$33.9M. Revenue was up 11.1% from 2023-12-31 to 2025-12-31. ATNM currently screens at market cap $33.9M.
When the next ATNM 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was up 11.1% from 2023-12-31 to 2025-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full ATNM research stays on the stock page; the tape stays on the quote page.
ATNM earnings FAQ
What are ATNM's latest revenue and net income?
Latest cached Actinium Pharmaceuticals Inc (ATNM) revenue for Dec 31, 2025 was $90.0K. Net income was -$33.9M. Statements: https://lician.com/financials/atnm
What is ATNM's latest diluted EPS?
Latest cached Actinium Pharmaceuticals Inc (ATNM) diluted EPS for Dec 31, 2025 was -$1.09.
What period does the latest ATNM earnings print cover?
The latest cached Actinium Pharmaceuticals Inc (ATNM) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2023.
How did ATNM revenue change from the prior cached period?
Cached Actinium Pharmaceuticals Inc (ATNM) revenue was up 11.1% from $81.0K (Dec 31, 2023) to $90.0K (Dec 31, 2025). Statements: https://lician.com/financials/atnm
Where are ATNM earnings listed?
Cached earnings facts for Actinium Pharmaceuticals Inc (ATNM) are listed at https://lician.com/earnings/atnm. Statements: https://lician.com/financials/atnm
Not investment advice.